blue cross blue shield fep glp 1 coverage of Massachusetts will stop covering popular GLP-1 weight-loss drugs like Ozempic and Wegovy starting January 1, 2026. The decision comes as the costs for these medications have Tier exceptions no longer allowed

Teer says, As a not-for-profit health system, our passion for people extends beyond the walls of our care sites and into the diverse communities we serve

Gut microbial metabolism of dietary fibre protects against high energy feeding induced ovarian follicular atresia in a pig model

Tier 4: Medical Intervention (When Indicated) Clinical obesity, type 2 diabetes, or other metabolic conditions requiring pharmaceutical management represent appropriate medical intervention contexts

Comparative assessment of lixisenatide, exenatide, and liraglutide pen devices: a pilot user-based study

Start your intake What GLP-1 Medications Do and How They Work GLP-1 (glucagon-like peptide-1) receptor agonists mimic a naturally occurring hormone that regulates blood sugar and appetite